Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Regulatory Science and Policy

Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research

Jan Van Deun, Pieter Mestdagh, Olivier De Wever, Jo Vandesompele and An Hendrix
Jan Van Deun
Ghent Univ. Hospital, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pieter Mestdagh
Ghent Univ. Hospital, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier De Wever
Ghent Univ. Hospital, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jo Vandesompele
Ghent Univ. Hospital, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An Hendrix
Ghent Univ. Hospital, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2017-LB-107 Published July 2017
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC

Abstract

Extracellular vesicles (EVs), also termed exosomes, mediate communication between cells and organisms through local and distant transport of proteins, nucleic acids and lipids. EVs are reported as biomarkers in cancer. However, transparent reporting is a prerequisite to facilitate interpretation and validation of EV biomarkers in cancer. We convened an international consortium to develop a resource to improve the rigor and interpretation of experiments, record the evolution of EV research and create a dialogue with researchers about relevant experimental parameters. We analyzed 1226 articles with keywords “exosomes” or “extracellular vesicles” published in 2010-2015. Publications that included multiple sample types or isolation methods were separated into multiple entries, resulting in 1742 experiments. Experiments were analyzed using a matrix containing 115 parameters related to sample type, EV isolation and characterization methods. The database is freely accessible and expandable, allowing online deposition of new experiments (http://evtrack.org). To assess current practice in EV experiments, we performed an in-depth analysis of recorded data in the EV-TRACK knowledgebase. This revealed heterogeneity in EV isolation methods and inconsistent reporting of experimental parameters. Differential ultracentrifugation is the most used method (>50%) but with a large heterogeneity in centrifugation steps. In less than 20% of experiments a density gradient was implemented to obtain or at least validate results. Quality controls are often omitted, with more than 2 proteins being checked in 40% and non-EV enriched proteins in less than 15% of experiments (dependent on sample type). From these analyses, 9 relevant experimental parameters were extracted and condensed into a single metric, the EV-METRIC (to MEasure Transparent Reporting of Isolation and Characterization methods). It represents a checklist to assess the completeness of reporting of generic and method-specific information necessary to interpret and validate an experiment. The EV-TRACK platform is a knowledge center for EV biology and methodology that allows data queries, coaches users by providing EV-METRICs and involves them in decision-making on future improvements to the platform. In conclusion, established for and supported by the EV research community, the EV-TRACK platform aims to ensure that experimental guidelines are timely and transparently met, improving the validation of EV biomarkers in cancer.

Citation Format: Jan Van Deun, Pieter Mestdagh, Olivier De Wever, Jo Vandesompele, An Hendrix. EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr LB-107. doi:10.1158/1538-7445.AM2017-LB-107

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 77 (13 Supplement)
July 2017
Volume 77, Issue 13 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Jan Van Deun, Pieter Mestdagh, Olivier De Wever, Jo Vandesompele and An Hendrix
Cancer Res July 1 2017 (77) (13 Supplement) LB-107; DOI: 10.1158/1538-7445.AM2017-LB-107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Jan Van Deun, Pieter Mestdagh, Olivier De Wever, Jo Vandesompele and An Hendrix
Cancer Res July 1 2017 (77) (13 Supplement) LB-107; DOI: 10.1158/1538-7445.AM2017-LB-107
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Regulatory Science and Policy

  • Abstract LB-338: A critical evaluation of genomic data sharing: Barriers to accessing pediatric cancer genomic datasets: a Treehouse Childhood Cancer Initiative experience
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-338: A critical evaluation of genomic data sharing: Barriers to accessing pediatric cancer genomic datasets: a Treehouse Childhood Cancer Initiative experience
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
Show more 3

Poster Presentations - Computational Tools and Databases

  • Abstract 2593: Accelerating pediatric brain tumor research through team science solutions
  • Abstract 2611: A crowdsourcing-based clinical trial information curation and searching system
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement